article Open AccessTop 1% cited
Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry
Annals of the Rheumatic Diseases · 2020 · Vol. 79(7) · pp. 859–866
Milena Gianfrancesco(University of California, San Francisco)Kimme L Hyrich(University of Manchester)Sarah Al-Adely(University of Manchester)Loreto Carmona(Instituto de Salud Musculoesquelética)Maria I. Danila(University of Alabama at Birmingham)Laure Gossec(Inserm)Zara Izadi(University of California, San Francisco)Lindsay Jacobsohn(University of California, San Francisco)Patricia Katz(University of California, San Francisco)Saskia Lawson‐Tovey(University of Manchester)Elsa F Mateus(Portuguese League Against Epilepsy)Stephanie Rush(University of California, San Francisco)Gabriela Schmajuk(University of California, San Francisco)Julia F. Simard(Stanford Medicine)Anja Strangfeld(German Rheumatism Research Centre)Laura Trupin(University of California, San Francisco)Katherine D. Wysham(University of Washington)Suleman Bhana(Crystal Run Healthcare)Wendy CostelloRebecca Grainger(University of Otago)Jonathan S. Hausmann(Boston Children's Hospital)David Liew(University of Washington)Emily Sirotich(Canadian Arthritis Patient Alliance)Paul Sufka(HealthPartners)Zachary S. Wallace(Harvard University)Jinoos Yazdany(University of California, San Francisco)Pedro Machado(London North West Healthcare NHS Trust)Philip C. Robinson✉(The University of Queensland)
COVID-19 Clinical Research StudiesDermatological and COVID-19 studiesAutoimmune and Inflammatory Disorders ResearchMedicineInternal medicineRheumatologyOdds ratioLogistic regressionHydroxychloroquinePrednisoneComorbidityCoronavirus disease 2019 (COVID-19)Epidemiology
MeSH terms
BetacoronavirusJanus Kinase InhibitorsTumor Necrosis Factor InhibitorsCOVID-19SARS-CoV-2AdolescentAdultAgedAnti-Inflammatory Agents, Non-SteroidalAntimalarialsArthritis, RheumatoidBiological ProductsFemaleGlucocorticoidsHospitalization
Citations
1,173
FWCI
26.78
field-weighted impact
References
42
Percentile
99%
vs. same field & year
Citations per year
Cited by
Post COVID immune phenomena: Expanded role of the Nephrologist
International journal of nephrology research. · 2023 · 0 citations
Aging, Immunity, and COVID-19: How Age Influences the Host Immune Response to Coronavirus Infections?
Frontiers in Physiology · 2021 · 500 citations
References
The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment
Lara D. Veeken · 2012 · 531 citations
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
The Lancet · 2020 · 51,571 citations
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
JAMA · 2020 · 17,926 citations
Clinical Characteristics of Coronavirus Disease 2019 in China
New England Journal of Medicine · 2020 · 31,047 citations
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China
Intensive Care Medicine · 2020 · 5,148 citations
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
The Lancet · 2020 · 28,983 citations
COVID-19: consider cytokine storm syndromes and immunosuppression
The Lancet · 2020 · 10,120 citations
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study
BMJ · 2020 · 4,150 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.
